文献速递帕金森病与运动障碍神经肌肉病

外周免疫生物标志物与神经退行性疾病:20年随访的前瞻性队列研究

Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow-up.
PubMed 文献 · Ann Neurol · 2019-10-18

该研究基于瑞典812073名参与者、随访至2011年的前瞻性队列,分析白细胞、IgG、触珠蛋白和尿酸与肌萎缩侧索硬化和帕金森病风险的关系。随访期间共发生585例ALS和3769例帕金森病。白细胞、触珠蛋白和尿酸浓度升高与帕金森病风险降低相关,但与ALS无统计学显著关联。

要点

  • 白细胞、触珠蛋白和尿酸升高与帕金森病风险降低相关。
  • 上述生物标志物与肌萎缩侧索硬化风险无显著关联。
  • 帕金森病患者诊断前数年即出现白细胞、触珠蛋白和尿酸水平降低。

核心结论

  • 白细胞、触珠蛋白和尿酸浓度升高与帕金森病风险降低相关,但与肌萎缩侧索硬化无显著关联。
  • 系统炎症在帕金森病与肌萎缩侧索硬化风险中可能扮演不同角色,尚需独立人群验证。

研究设计与样本

  • 瑞典载脂蛋白相关死亡风险研究为纵向队列,纳入812073名在1985至1996年间有重复血液生物标志物测量的参与者,随访至2011年。
  • 采用Cox模型估计白细胞、免疫球蛋白G、触珠蛋白和尿酸与肌萎缩侧索硬化及帕金森病风险的风险比。

主要发现

  • 随访期间共识别585例肌萎缩侧索硬化 incident 病例和3769例帕金森病 incident 病例。
  • 白细胞、触珠蛋白和尿酸浓度升高与帕金森病风险降低相关。
  • 所研究的生物标志物与肌萎缩侧索硬化之间无统计学显著关联。
  • 帕金森病患者在诊断前20至10年白细胞和触珠蛋白水平较低,诊断前20年内尿酸水平较低,但多变量调整后仅在部分时间区间有统计学显著差异。
  • 肌萎缩侧索硬化患者与对照之间未见明显差异。

临床怎么用

  • 对于帕金森病风险人群,可关注外周白细胞、触珠蛋白和尿酸水平的变化趋势。
  • 上述生物标志物目前不宜作为肌萎缩侧索硬化的风险预测指标。

局限性

  • 研究结果需在独立人群中验证。
  • 帕金森病患者生物标志物差异在多变量调整后仅部分时间区间有统计学显著性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the associations of several blood immune biomarkers with the future risks of amyotrophic lateral sclerosis and Parkinson disease in a prospective cohort study with 20 years of follow-up. METHODS: The Swedish Apolipoprotein-Related Mortality Risk study is a longitudinal cohort study including 812,073 participants with repeated blood biomarker measurements between 1985 and 1996 and a follow-up until 2011. Using a Cox model, we first estimated hazard ratios of amyotrophic lateral sclerosis and Parkinson disease in relation to leukocytes, immunoglobulin G, haptoglobin, and uric acid. We further described the temporal changes of these biomarkers during the 20 years prior to the diagnosis of these diseases. RESULTS: A total of 585 incident cases of amyotrophic lateral sclerosis and 3,769 incident cases of Parkinson disease were identified during the follow-up. Increasing concentrations of leukocytes, haptoglobin, and uric acid were associated with a lower risk of Parkinson disease. No statistically significant association was, however, noted between the studied biomarkers and amyotrophic lateral sclerosis. Parkinson disease patients appeared to have lower levels of leukocytes and haptoglobin between 20 and 10 years before diagnosis and lower levels of uric acid during the 20 years before diagnosis, compared to controls, although statistically significant differences were only noted during parts of the respective time intervals after multivariable adjustment. No clear differences were noted between patients with amyotrophic lateral sclerosis and controls. INTERPRETATION: If verified in studies of independent populations, our findings may suggest a different role of systemic inflammation on the risk of Parkinson disease compared to amyotrophic lateral sclerosis. ANN NEUROL 2019;86:913-926.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Yazdani S, Mariosa D, Hammar N, et al. Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow-up. Ann Neurol. 2019. PMID: 31604369. doi:10.1002/ana.25614

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。